ARTAL GROUP S.A. – Kymera Therapeutics, Inc. Transaction History
ARTAL GROUP S.A. portfolio value:
$32.65M
portfolio value
ARTAL GROUP S.A. quarter portfolio value change:
+10.56%
quarter
Kymera Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +50.00% | 500K shares | 12.96M | $21.77 | 1.5M |
| Q2 2022 | share | 0.00% | 0 shares | -22.63M | $19.69 | 1M | |
| Q1 2022 | share | 0.00% | 0 shares | -21.17M | $42.32 | 1M | |
| Q4 2021 | share | Increase | +150.00% | 600K shares | 39.99M | $62.98 | 1M |
| Q3 2021 | share | Increase | +60.00% | 150K shares | 11.37M | $58.74 | 400K |
| Q2 2021 | share | 0.00% | 0 shares | 2.41M | $48.5 | 250K | |
| Q1 2021 | share | 0.00% | 0 shares | -5.78M | $38.86 | 250K | |
| Q4 2020 | share | 0.00% | 0 shares | 7.42M | $62 | 250K | |
| Q3 2020 | share | Increase | 0.00% | 250K shares | 8.07M | $32.31 | 250K |